tiprankstipranks
Trending News
More News >
Advanced Flower Capital Inc. (AFCG)
NASDAQ:AFCG

AFC Gamma (AFCG) AI Stock Analysis

Compare
668 Followers

Top Page

AFCG

AFC Gamma

(NASDAQ:AFCG)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 5.2)
Rating:48Neutral
Price Target:
$2.50
â–²(6.84% Upside)
Action:ReiteratedDate:01/29/26
A low overall score is driven primarily by the sharp deterioration in TTM profitability/revenue and weak price/momentum trends. Strategic positives from the BDC transition and added liquidity help, but are outweighed by ongoing credit issues, dividend uncertainty, and loss-driven valuation signals.
Positive Factors
BDC conversion broadens mandate
Converting from a REIT to a BDC is a structural change that expands permissible investments and regulatory framework. This broadens deal sourcing beyond cannabis real estate, enabling diversified lending and portfolio construction that can reduce sector concentration risk and support steadier earnings over time.
Positive operating and free cash flow
Sustained positive operating and free cash flow provides internal funding for operations and opportunistic originations without immediate reliance on external capital. Strong FCF growth supports working capital needs, loan workouts, and a measured path to deleveraging if earnings recover, improving long-run resilience.
Large origination pipeline and diversification
A $350M pipeline, primarily outside cannabis, signals durable origination capacity and successful diversification. Expanding into non-cannabis direct lending can smooth cyclicality, broaden borrower credit profiles, and increase opportunities for higher utilization and fee income over the medium term if pipeline converts to closed loans.
Negative Factors
Sharp deterioration in profitability and revenue
A major swing to negative TTM revenue and a -$22.6M net loss represent a structural earnings disruption. Persistent revenue decline and negative margins reduce internal capital generation, constrain dividend capacity, and increase the imperative to restore underwriting performance to avoid long-term balance-sheet erosion.
Elevated credit stress and reserve build
Nonaccrual loans and a CECL reserve equal to 18.7% of loan carrying value indicate meaningful credit losses and recovery uncertainty. Elevated loss provisioning can compress net interest margin and capital, limit new originations, and make future earnings dependent on workout outcomes rather than organic loan growth, a persistent constraint.
Reliance on related‑party funding raises governance risk
A material related‑party credit facility improves near-term liquidity but concentrates funding with insiders and invites governance scrutiny. Structural reliance on affiliate financing can limit bargaining leverage, complicate future capital raises, and create perceived conflicts that affect long-term investor confidence and strategic flexibility.

AFC Gamma (AFCG) vs. SPDR S&P 500 ETF (SPY)

AFC Gamma Business Overview & Revenue Model

Company DescriptionAdvanced Flower Capital, Inc. provides commercial real estate finance services. It primarily engages in originating, structuring, underwriting and managing senior secured loans and other types of loans for established companies operating in the cannabis industry in states. The company was founded by Leonard Mark Tannenbaum on July 6, 2020 and is headquartered in West Palm Beach, FL.
How the Company Makes MoneyAFC Gamma generates revenue primarily through interest income from loans and credit facilities extended to cannabis operators. The company typically structures its loans with competitive interest rates, often secured by the underlying real estate and operating assets of the borrowers. Additional revenue streams may include origination fees, late fees, and other service fees associated with their financing products. AFCG's strategic partnerships with licensed cannabis operators and its expertise in assessing the unique risk factors of the cannabis industry contribute to its ability to underwrite loans effectively, enhancing its revenue potential. The growth of legal cannabis markets across various states and countries also serves as a significant factor driving demand for AFC Gamma's financial services.

AFC Gamma Earnings Call Summary

Earnings Call Date:Nov 12, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 04, 2026
Earnings Call Sentiment Neutral
The call highlighted significant shareholder support for the conversion to a BDC and successful loan repayments, indicating strategic growth and diversification opportunities. However, financial challenges, including a net loss, non-performing loans, and dividend suspension, reflect ongoing operational hurdles.
Q3-2025 Updates
Positive Updates
Shareholder Approval for BDC Conversion
Over 94% of votes cast were in favor of the proposals to convert from a REIT to a BDC, showing strong shareholder support and engagement.
Successful Loan Payoffs
Private Company J paid off its term loan ahead of maturity, totaling $23,200,000. A subsidiary of Public Company S also paid off their term loan, contributing to $43,000,000 of principal repayments since Q2.
Expanded Investment Mandate
Board approval of an expanded investment mandate includes direct lending opportunities outside the cannabis industry, broadening the company's investment universe.
Pipeline Development
Advanced Flower Capital has built a pipeline of approximately $350,000,000 for 2026, focusing on both cannabis and non-cannabis lending opportunities.
Negative Updates
Net Loss and Distributable Earnings
The company reported a GAAP net loss of $12,500,000 or $0.57 per basic weighted average share, despite generating distributable earnings of $3,500,000 or $0.16 per share.
Non-Performing Loans Impact
Private Company P's loan moved to nonaccrual status, resulting in an anticipated taxable loss of approximately $4,000,000, affecting Q4 earnings.
Challenges with Underperforming Loans
Ongoing challenges in liquidating assets from Private Company A and securing value from Justice Grown, with pending legal actions and uncertain recoveries.
Dividend Suspension for Q4 2025
No distribution to shareholders in Q4 due to anticipated losses, with the go-forward dividend policy to be reevaluated in conjunction with the BDC transition.
Company Guidance
During the Q3 2025 earnings call for Advanced Flower Capital Inc., several key metrics and guidance elements were discussed. The company generated distributable earnings of $0.16 per basic weighted average share and declared a third-quarter dividend of $0.15 per common share, paid on October 15, 2025. The firm is transitioning from a mortgage REIT to a Business Development Company (BDC), with shareholder approval for this change having been secured with over 94% of votes in favor. This transition, anticipated to complete in 2026, is expected to broaden their investment mandate beyond real estate and cannabis, allowing for diversification. As of September 30, 2025, the company had a total of $332.8 million in principal outstanding across 14 loans, with a capital pipeline of approximately $350 million, mostly outside cannabis. The Board continues to evaluate quarterly dividends, especially given a $4 million anticipated taxable loss, and has decided not to distribute dividends in Q4 2025. The company's CECL reserve was reported at $51.3 million, representing 18.7% of loans at carrying value.

AFC Gamma Financial Statement Overview

Summary
Financial performance has weakened materially: TTM results show sharply negative revenue/margins and a sizable net loss, a break from prior-year profitability. Leverage appears moderate, but negative ROE and shrinking equity raise balance-sheet risk if losses persist. Positive and growing operating/free cash flow provides some cushion, though debt coverage remains only moderate.
Income Statement
28
Negative
Profitability and growth have deteriorated sharply in the most recent period. TTM (Trailing-Twelve-Months) revenue is negative and margins turned deeply negative (net income of about -$22.6M), a major break from the prior years’ solid profitability (2021–2024 net margins were consistently positive). Revenue also shifted from modest declines in 2023–2024 to an extreme contraction in TTM (reported revenue growth around -130%), indicating elevated earnings volatility and weak near-term operating momentum.
Balance Sheet
54
Neutral
Leverage looks moderate on the latest balance sheet, with TTM (Trailing-Twelve-Months) debt-to-equity around 0.53 and equity (~$169M) still supporting the asset base (~$289M). However, returns on equity have flipped negative in TTM (about -12%), and equity has declined versus prior years, reflecting losses and potential balance-sheet pressure if weak performance persists. Debt levels have also been volatile year-to-year, which adds financial risk for a specialty REIT.
Cash Flow
63
Positive
Cash generation is a relative bright spot: TTM (Trailing-Twelve-Months) operating cash flow and free cash flow were positive at about $14.0M, with strong reported free-cash-flow growth (~33%). That said, cash flow covers only a modest portion of total debt (operating cash flow to total debt ~0.16 in TTM), implying limited deleveraging capacity without an earnings recovery. Overall, cash flow is holding up better than reported net income, but debt coverage remains a key watch item.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue-2.21M51.90M51.80M71.54M38.08M11.48M
Gross Profit-2.21M41.49M51.80M60.36M35.43M11.48M
EBITDA-5.74M20.65M0.0081.95M38.59M0.00
Net Income-22.58M16.78M20.95M35.93M21.00M10.35M
Balance Sheet
Total Assets288.72M402.06M466.59M519.18M464.85M93.96M
Cash, Cash Equivalents and Short-Term Investments45.12M103.61M90.38M140.37M125.13M9.62M
Total Debt111.06M188.61M130.01M157.13M171.42M0.00
Total Liabilities119.38M200.68M146.53M180.12M191.77M2.31M
Stockholders Equity169.34M201.38M320.05M339.06M273.08M91.65M
Cash Flow
Free Cash Flow14.02M21.56M21.23M31.32M9.54M1.52M
Operating Cash Flow14.02M21.56M21.23M31.32M9.54M1.52M
Investing Cash Flow-33.09M-4.85M28.52M-16.34M-248.46M-32.43M
Financing Cash Flow-57.97M-34.72M-68.49M16.15M338.54M40.53M

AFC Gamma Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.34
Price Trends
50DMA
2.55
Negative
100DMA
2.87
Negative
200DMA
3.64
Negative
Market Momentum
MACD
-0.05
Negative
RSI
45.42
Neutral
STOCH
74.06
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AFCG, the sentiment is Negative. The current price of 2.34 is above the 20-day moving average (MA) of 2.25, below the 50-day MA of 2.55, and below the 200-day MA of 3.64, indicating a neutral trend. The MACD of -0.05 indicates Negative momentum. The RSI at 45.42 is Neutral, neither overbought nor oversold. The STOCH value of 74.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AFCG.

AFC Gamma Risk Analysis

AFC Gamma disclosed 92 risk factors in its most recent earnings report. AFC Gamma reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

AFC Gamma Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
$567.73M23.216.67%14.23%-9.27%333.85%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
48
Neutral
$51.52M-2.19-12.03%30.82%-47.13%-361.12%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AFCG
AFC Gamma
2.28
-5.26
-69.77%
PW
Power REIT
0.89
-0.16
-15.24%
FPI
Farmland
13.04
1.89
16.91%

AFC Gamma Corporate Events

Business Operations and StrategyPrivate Placements and Financing
AFC Gamma Secures $20 Million Related-Party Credit Facility
Positive
Jan 29, 2026

On January 27, 2026, Advanced Flower Capital Inc. entered into an unsecured revolving credit agreement with TCGSL LLC, an affiliate controlled by Chairman Leonard M. Tannenbaum and his family, providing a $20 million aggregate commitment maturing on August 1, 2028. The new facility, which may be used for general corporate purposes including portfolio investments, enhances the company’s financial flexibility and access to liquidity, potentially supporting its ongoing investment activities and capital deployment strategy while involving a related-party lender structure that may be of particular interest to governance-focused stakeholders.

The most recent analyst rating on (AFCG) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on AFC Gamma stock, see the AFCG Stock Forecast page.

Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
AFC Gamma Amends Loan Agreement After BDC Conversion
Positive
Jan 16, 2026

On January 13, 2026, Advanced Flower Capital Inc. entered into a Sixth Amendment to its Loan and Security Agreement, originally dated April 29, 2022, with its existing lender group and lead arranger. The amendment updates the facility to include provisions tailored to the company’s recent conversion from a real estate investment trust to a business development company, signaling a formal alignment of its financing arrangements with its new regulatory and operational framework and potentially enhancing its flexibility to pursue its evolving lending strategy.

The most recent analyst rating on (AFCG) stock is a Sell with a $2.50 price target. To see the full list of analyst forecasts on AFC Gamma stock, see the AFCG Stock Forecast page.

Business Operations and Strategy
AFC Gamma Completes Strategic Conversion to BDC Structure
Positive
Jan 5, 2026

On January 1, 2026, Advanced Flower Capital completed its previously announced conversion from a real estate investment trust to a business development company regulated under the Investment Company Act of 1940, a move formally announced in a January 5, 2026 press release and accompanied by a new investment advisory agreement with AFC Management that will govern management and incentive fees from that date. In connection with the conversion, the company overhauled its governance and operating framework by terminating its prior management agreement without a termination fee, adopting new bylaws and lifting REIT-related ownership restrictions, and entering into new administration, custody, transfer agency and services agreements that collectively formalize its BDC infrastructure, broaden its investment remit beyond real estate-backed loans to a wider universe of operating businesses, and are intended to support AFC’s ability to pursue a deeper pipeline of opportunities and generate attractive risk-adjusted returns for shareholders while maintaining its existing Nasdaq listing under the ticker AFCG.

The most recent analyst rating on (AFCG) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on AFC Gamma stock, see the AFCG Stock Forecast page.

Business Operations and StrategyShareholder Meetings
AFC Gamma Shareholders Approve REIT to BDC Conversion
Positive
Nov 6, 2025

On November 6, 2025, Advanced Flower Capital Inc. announced that its shareholders approved proposals to convert the company from a real estate investment trust (REIT) to a business development company (BDC) regulated under the Investment Company Act of 1940. This strategic shift, marked by the approval of a new investment advisory agreement and reduced asset coverage requirements, is expected to broaden AFC’s investment scope beyond real estate-backed loans, enabling it to pursue a wider range of market opportunities and enhance its ability to generate consistent, risk-adjusted returns. The conversion, pending board approval, is anticipated to be completed in the first quarter of 2026, with AFC continuing to trade under its existing Nasdaq ticker symbol, AFCG.

The most recent analyst rating on (AFCG) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on AFC Gamma stock, see the AFCG Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 29, 2026